Wednesday Papers: Genzyme chief signals departure - tips, comment and bids

Financial Times

* Genzyme’s chief executive, Henri Termeer, could step down next summer and ease a takeover of the biotechnology business by Sanofi-Aventis of France.

The Lex Column

* Tablet unlikely to solve RIM malaise - The BlackBerry maker needs to convince shareholders it has a clear strategy.

* Rare earths - China has a dominant grip on the market for coveted metallic elements.

* Michelin - Deeply discounted rights issue punctures share price.

* Man Group - The world’s biggest listed hedge fund group faces a tough second half.

* Brazilian asset management - Biggest groups scramble to get in on the game.

Lombard

* Mail’s money man earns access to higher places - No catastrophe at Lloyd’s - Lehman’s lost lots.

Global Insight

* Germany’s defence of euro has its limits - Leaving eurozone without a safety net would be risky.